Human cancer cell lines: fact and fantasy
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Cancer cell lines are used in many biomedical research laboratories. Why, then, are they often described as unrepresentative of the cells from which they were derived? Here, I argue that they have been unjustly accused. Under the right conditions, and with appropriate controls, properly authenticated cancer cell lines retain the properties of the cancers of origin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cell lines from different tissues may be distinguishable using phenotypic markers, although it should be noted that phenotypic markers can be affected by the degree of differentiation shown by each cell line and their length of time in culture.1,3”
From Match criteria for human cell line authentication: Where do we draw the line? (2013) · cites this paper as [1]
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925 · cited 1×
“For the patient, this advance will facilitate individualized drug therapy, autologous immunotherapy, and more accurate molecular staging and prognosis using transcriptome and proteome analyse”
BackgroundCulture of Animal Cells: A Manual of Basic Technique and Specialized Applications
Freshney, R. I. (2010) · Wiley eBooks · doi:10.1002/9780470649367 · Cited by 3,870
Systematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088 · cited 1×
“Complementary DNA microarray studies of over 8,000 genes in 60 human cancer cell lines revealed consistent similarities between cell lines from the same tissue of origin, and consistent differences between cell lines of different origin”
BackgroundOne Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23
Fogh, J., Fogh, J. M., & Orfeo, T. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/59.1.221 · Cited by 1,599
Culture of Animal Cells: A Manual of Basic Technique
(1985) · Food and Chemical Toxicology · doi:10.1016/0278-6915(85)90082-1 · Cited by 1,249
(1952) · Cancer Research · Cited by 987
Drexler, H. (1998) · Leukemia · doi:10.1038/sj.leu.2401043 · Cited by 426
Widespread intraspecies cross-contamination of human tumor cell lines arising at source
MacLeod, R. A. F., Dirks, W. G., Matsuo, Y., Kaufmann, M., Milch, H., & Drexler, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<555::aid-ijc19>3.0.co;2-2 · Cited by 364
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas
Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1303 · Cited by 355
Cross-contamination of cells in culture
Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329 · cited 1×
“He showed that a large proportion of the cell lines being used worldwide and being distributed by cell banks were HeLa cell”
Background
Research works printed but not linked: 6
- Lansford, C. D. et al. in Human Cell Culture Volume 2, Cancer Cell Lines Part 2 (eds Masters, J. R. W. & Palsson, B.) 185–255 (Kluwer Academic, Dordrecht, 1999).
- Wistuba, I. I. et al. Comparison of features of human lung cancer cell lines and their corresponding tumours. Clin. Cancer Res. 5, 991–1000 (1999).
- Walker, M. C., Parris, C. N. & Masters, J. R. W. Differential sensitivities to chemotherapeutic drugs between testicular and bladder cancer cells. J. Natl Cancer Inst 79, 213–216 ( 1987).
- Knuechel, R. & Masters, J. R. W. in Human Cell Culture Volume 1, Cancer Cell Lines Part 1 (eds Masters, J. R. W. & Palsson, B.) 213–230 (Kluwer Academic, Dordrecht, 1999).
- Gold, M. A Conspiracy of Cells. One Woman's Immortal Legacy and the Scandal It Caused (State University of New York, Albany, 1986).
- MacLeod, R. A. F. & Drexler, H. G. in Human Cell Culture Volume 3, Leukemias and Lymphomas (eds Masters, J. R. W. & Palsson, B.) 373–399 (Kluwer Academic, Dordrecht, 2000).
Cited by
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951
Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems
Birgersdotter, A., Sandberg, R., & Ernberg, I. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.009 · Cited by 591
Pan, C., Kumar, C., Bohl, S., Klingmueller, U., & Mann, M. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800258-mcp200 · Cited by 561
HeLa cells 50 years on: the good, the bad and the ugly
Masters, J. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc775 · Cited by 560
Self-citationCheck your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520
“The changes seen throughout this process have many parallels within cancer development, both for malignancy in general and when considering specific tumor types.(7,8)”
BackgroundSelf-citationHickman, J. A., Graeser, R., de Hoogt, R., Vidic, S., Brito, C., Gutekunst, M., van der Kuip, H., & IMI PREDECT consortium (2014) · Biotechnology Journal · doi:10.1002/biot.201300492 · Cited by 380
“Furthermore, tissue slice culture has the potential to cover the whole clinical spectrum of solid tumors including all stages and grades from well-differentiated slow-growing to poorly differentiated fast-growing subtypes, whereas the vast majority of cell lines represent only high-stage and poorly differentiated tumo…”
BackgroundRoots and stems: stem cells in cancer
Polyak, K., & Hahn, W. C. (2006) · Nature Medicine · doi:10.1038/nm1379 · Cited by 378
Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages
Taciak, B., Białasek, M., Braniewska, A., Sas, Z., Sawicka, P., Kiraga, Ł., Rygiel, T., & Król, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198943 · Cited by 377
Organoid cultures for the analysis of cancer phenotypes
Sachs, N., & Clevers, H. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.012 · Cited by 371
“Disadvantages such as genotypic drift and cross-contamination can usually be prevented by rigorous quality control and freezing well-characterized, low passage stocks [11].”
BackgroundCoecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371
Luca, A. C., Mersch, S., Deenen, R., Schmidt, S., Messner, I., Schäfer, K.-L., Baldus, S. E., Huckenbeck, W., Piekorz, R. P., Knoefel, W. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059689 · Cited by 341
“advanced cancers with progressed genotypes [1].”
BackgroundCancer Cell Lines Are Useful Model Systems for Medical Research
Mirabelli, P., Coppola, L., & Salvatore, M. (2019) · Cancers · doi:10.3390/cancers11081098 · Cited by 336
“However, it is important to highlight two outstanding problems that persist and that are related to their use: cross-contamination [19,58] and mycoplasma infection [1,59].”
BackgroundInfluentialArticular cartilage: from formation to tissue engineering
Camarero-Espinosa, S., Rothen-Rutishauser, B., Foster, E. J., & Weder, C. (2016) · Biomaterials Science · doi:10.1039/c6bm00068a · Cited by 328
Breast cancer cell lines: friend or foe?
Burdall, S. E., Hanby, A. M., Lansdown, M. R., & Speirs, V. (2003) · Breast Cancer Research · doi:10.1186/bcr577 · Cited by 322
“The increasing misuse of ‘false’ cell lines has recently come to light in the literature, with the observation that of 252 new cell lines deposited at the German Cell Line Bank, nearly one-fifth of these (18%) were found to be cross-contaminants [5,6].”
BackgroundLIFE ISN'T FLAT: TAKING CANCER BIOLOGY TO THE NEXT DIMENSION
SMALLEY, K. S. M., LIONI, M., & HERLYN, M. (2006) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0604027.1 · Cited by 302
“There is experimental evidence that human tumor cell lines grown in culture can be representative of the original tumor lesion (Masters, 2000).”
BackgroundInfluentialHuman cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
van Staveren, W. C. G., Solís, D. Y. W., Hébrant, A., Detours, V., Dumont, J. E., & Maenhaut, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.004 · Cited by 222
Cariati, M., Naderi, A., Brown, J. P., Smalley, M. J., Pinder, S. E., Caldas, C., & Purushotham, A. D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23103 · Cited by 214
“In solid malignancies, it has been shown that only a minority of cells have the ability to form colonies in vitro or give rise to neoplastic growth when injected in immuno-deficient mice.(6,7) This could be explained by the fact that all tumour cells are similar, and extensive proliferation is merely a stochastic phen…”
BackgroundCuring metastatic cancer: lessons from testicular germ-cell tumours
Masters, J. R. W., & Köberle, B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1120 · Cited by 208
Self-citationMohseny, A. B., Machado, I., Cai, Y., Schaefer, K.-L., Serra, M., Hogendoorn, P. C. W., Llombart-Bosch, A., & Cleton-Jansen, A.-M. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.72 · Cited by 206
False leukemia–lymphoma cell lines: an update on over 500 cell lines
Drexler, H. G., Dirks, W. G., Matsuo, Y., & MacLeod, R. A. F. (2003) · Leukemia · doi:10.1038/sj.leu.2402799 · Cited by 202
Tyrosine kinase receptors as attractive targets of cancer therapy
Bennasroune, A., Gardin, A., Aunis, D., Crémel, G., & Hubert, P. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.08.004 · Cited by 197
Match criteria for human cell line authentication: Where do we draw the line?
Capes‐Davis, A., Reid, Y. A., Kline, M. C., Storts, D. R., Strauss, E., Dirks, W. G., Drexler, H. G., MacLeod, R. A. F., Sykes, G., Kohara, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27931 · Cited by 180
Self-citationOliveira, P. A., Colaço, A., Chaves, R., Guedes-Pinto, H., De-La-Cruz P., L. F., & Lopes, C. (2007) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652007000400004 · Cited by 185
“Some scientists have questioned whether cells in culture maintain their bioactivation and detoxification mechanisms (Masters 2000, Gutiérrez and Salsamendi 2001).”
Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli
Kong, L., Smith, W., & Hao, D. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14277 · Cited by 177
Sandberg, R., & Ernberg, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408105102 · Cited by 169
Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
Fujii, M., & Sato, T. (2021) · Nature Materials · doi:10.1038/s41563-020-0754-0 · Cited by 165
Ex Vivo Tumor Culture Systems for Functional Drug Testing and Therapy Response Prediction
Meijer, T. G., Naipal, K. A., Jager, A., & van Gent, D. C. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0003 · Cited by 161
Persistent use of “false” cell lines
Lacroix, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23233 · Cited by 151
Praharaj, P. P., Bhutia, S. K., Nagrath, S., Bitting, R. L., & Deep, G. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.005 · Cited by 147
“…fall short of expectations as an effective clinically relevant model because of issues related to genotypic drift, cross-contamination with other cell lines, difficulty in establishment of permanent cell lines from primary tumors, loss of tumor heterogeneity, and adaptation to in vitro growth [71].”
A comparison of in vitro cytotoxicity assays in medical device regulatory studies
Liu, X., Rodeheaver, D. P., White, J. C., Wright, A. M., Walker, L. M., Zhang, F., & Shannon, S. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.06.003 · Cited by 159
Translational applications of adult stem cell-derived organoids
Drost, J., & Clevers, H. (2017) · Development · doi:10.1242/dev.140566 · Cited by 137
“Moreover, most cancer cell lines are derived from metastatic and fast growing tumors that already contain all the driver mutations required to become a full-blown metastatic tumor cell (Masters, 2000).”
Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell Lines
Boonstra, J. J., van Marion, R., Beer, D. G., Lin, L., Chaves, P., Ribeiro, C., Pereira, A. D., Roque, L., Darnton, S. J., Altorki, N. K., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp499 · Cited by 127
The art and design of genetic screens: mammalian culture cells
Grimm, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1291 · Cited by 137
Rambow, F., Job, B., Petit, V., Gesbert, F., Delmas, V., Seberg, H., Meurice, G., Van Otterloo, E., Dessen, P., Robert, C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.037 · Cited by 118
“Cancer-derived cell lines also are used in drug discovery, but may differ from the tumor of origin (Ertel et al., 2006; Gillet et al., 2013; Masters, 2000).”
Nelson, A. W., Groen, A. J., Miller, J. L., Warren, A. Y., Holmes, K. A., Tarulli, G. A., Tilley, W. D., Katzenellenbogen, B. S., Hawse, J. R., Gnanapragasam, V. J., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.016 · Cited by 128
“Whilst we acknowledge that immortalized cell lines may have variable expression of certain factors across passage numbers and laboratories (Masters, 2000), our data suggest the need for caution in making this assumption with respect to ERb.”
ResultYu, S., Kim, T., Yoo, K. H., & Kang, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.114 · Cited by 151
Hallas-Potts, A., Dawson, J. C., & Herrington, C. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-41941-4 · Cited by 110
DeBord, L. C., Pathak, R. R., Villaneuva, M., Liu, H., Harrington, D. A., Yu, W., Lewis, M. T., & Sikora, A. G. (2018) · Europe PMC (PubMed Central) · Cited by 112
Liu, Q., Russell, M. R., Shahriari, K. S., Jernigan, D. L., Lioni, M., Garcia, F. U., & Fatatis, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3970 · Cited by 111
“5 genotypic and phenotypic changes (17).”
Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines
Wink, M. R., Lenz, G., Braganhol, E., Tamajusuku, A. S. K., Schwartsmann, G., Sarkis, J. J. F., & Battastini, A. M. O. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00308-2 · Cited by 110
“The fact that these results were found in four independently isolated human glioma cell lines and one rat cell line, that are representative models of extremely aggressive cancer cells [41,42], strongly suggests that this is a feature shared by several gliomas.”
Result(2001) · PubMed · Cited by 106
Preclinical models of pancreatic ductal adenocarcinoma
Hwang, C., Boj, S. F., Clevers, H., & Tuveson, D. A. (2016) · The Journal of Pathology · doi:10.1002/path.4651 · Cited by 105
“Second, while epithelial cells proliferate as polarized and well-organized structures in vivo, PDA cell lines propagated as monolayer cultures lack this structural organization and functional differentiation [24,25].”
BackgroundNeurodevelopmental origins of bipolar disorder: iPSC models
O'Shea, K. S., & McInnis, M. G. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.006 · Cited by 116
Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies
Chu, P.-Y., Koh, A. P.-F., Antony, J., & Huang, R. Y. (2021) · Cells Tissues Organs · doi:10.1159/000513039 · Cited by 108
“Cells might possess inherent demerits after passages with unexpected genetic instabilities [Masters, 2000; Sachs and Clevers, 2014].”
BackgroundYoon, Y., Kim, D., Tak, K. Y., Hwang, S., Kim, J., Sim, N. S., Cho, J.-M., Choi, D., Ji, Y., Hur, J. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30934-z · Cited by 118
“Furthermore, previous 2D cultures enabled the survival of culture-competent cells only during primary cell culture 73,74 .”
Boesch, M., Zeimet, A. G., Reimer, D., Schmidt, S. U., Gastl, G. A., Parson, W., Spoeck, F., Hatina, J., Wolf, D. G. F., & Sopper, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2053 · Cited by 100
“com/oncotarget We have used established ovarian carcinoma cell lines to initially address CSC and their heterogeneity assuming that these models provide a very robust basis for primary screening [29].”
MethodFolate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization
Siwowska, K., Schmid, R. M., Cohrs, S., Schibli, R., & Müller, C. (2017) · Pharmaceuticals · doi:10.3390/ph10030072 · Cited by 102
“In the past, this cell line was believed to be a human nasopharyngeal epidermal carcinoma cell line [25–28], however, later it became obvious that the KB cell line was established via contamination by HeLa cells, a cervical cancer cell line [29,30].”
BackgroundCurrent Status of Patient-Derived Ovarian Cancer Models
Maru, Y., & Hippo, Y. (2019) · Cells · doi:10.3390/cells8050505 · Cited by 95
The Unreliability of MTT Assay in the Cytotoxic Test of Primary Cultured Glioblastoma Cells
Jo, H. Y., Kim, Y., Park, H. W., Moon, H. E., Bae, S., Kim, J., Kim, D. G., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.3.235 · Cited by 86
“The immortalized glioblastoma cell line has experienced the process of immortalization and would lose or acquire some functional or structural changes [7].”
BackgroundCudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
Guidance on Good Cell Culture Practice
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G. J. A., Härtung, T., Hay, R. J., Bal‐Price, A., Merten, O., Stokes, W. S., et al. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5476-1_49 · Cited by 87
The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles
Sandberg, R., & Ernberg, I. (2005) · Genome Biology · doi:10.1186/gb-2005-6-8-r65 · Cited by 84
“Discussion The use of immortalized cell lines as model systems of normal and pathological tissues is controversial [5,26-28].”
BackgroundImmortalization and Transformation of Human Cells
C. Hahn, W. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15045-x · Cited by 84
Hartman, Z. C., Black, E. P., & Amalfitano, A. (2006) · Virology · doi:10.1016/j.virol.2006.08.041 · Cited by 87
“This approach was selected to reduce variability, as well to avoid clonal drift and potential epigenetic influences present in many immortalized cell lines (Masters, 2000).”
BackgroundKoues, O. I., Kowalewski, R., Chang, L., Pyfrom, S., Schmidt, J. A., Luo, H., Sandoval, L., Hughes, T. B., Bednarski, J. J., Cashen, A. F., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.021 · Cited by 93
“…purified malignant cells from primary tumors with normal counterparts rather than using unsorted biopsy samples containing amixture of cell types, or cancer lines, which accumulatewidespread revisions to the genome and epigenome during long-term culture (Masters, 2000; Victora et al., 2012).”
BackgroundCoussens, N. P., Braisted, J. C., Peryea, T., Sittampalam, G. S., Simeonov, A. M., & Hall, M. D. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.013755 · Cited by 81
“Cancer cell lines maintained in laboratories for many years are recognized to be limited in their relationship to the clinical cancer from which they were derived (Masters, 2000).”
BackgroundConjugated polymers as nanoparticle probes for fluorescence and photoacoustic imaging
Abelha, T. F., Dreiss, C. A., Green, M., & Dailey, L. A. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02582k · Cited by 80
Watt, S. A., Pourreyron, C., Purdie, K., Hogan, C., Cole, C. L., Foster, N., Pratt, N., Bourdon, J.-C., Appleyard, V, Murray, K., et al. (2011) · Oncogene · doi:10.1038/onc.2011.180 · Cited by 76
“…as demonstrable cancer targets we re-enforce the notion that although cultured tumor cells fall short of faithfully replicating the complex nature of human cancers, they are nevertheless invaluable in our goal to understand and ultimately treat this disease (Masters, 2000; Sharma et al., 2010).”
BackgroundStudying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology
Sasaki, N., & Clevers, H. C. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.09.001 · Cited by 81
p53 Superfamily Proteins in Marine Bivalve Cancer and Stress Biology
Walker, C. W., Beneden, R. J. V., Muttray, A. F., Böttger, S. A., Kelley, M. L., Tucker, A. E., & Thomas, W. K. (2011) · Advances in marine biology · doi:10.1016/b978-0-12-385536-7.00001-7 · Cited by 81
“In these cultures some cells will occasionally acquire mutations that make them immortal and even tumorigenic (Masters, 2000).”
BackgroundFunctional interpretation of non‐coding sequence variation: Concepts and challenges
Paul, D. S., Soranzo, N., & Beck, S. (2013) · BioEssays · doi:10.1002/bies.201300126 · Cited by 81
“However, chromosomal rearrangements, changes to chromatin structure, DNA methylation, and gene expression profiles may arise through, for example, serial subculturing of the cell lines [25].”
BackgroundHsu, C., Yu, J., Peng, P., Liu, S., Chang, Y., Chang, K., & Wu, C. (2014) · Journal of Proteome Research · doi:10.1021/pr500038k · Cited by 73
Qiu, Z., Zou, K., Zhuang, L., Qin, J., Li, H., Li, C., Zhang, Z., Chen, X., Cen, J., Meng, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27411 · Cited by 73
Mix-ups and mycoplasma: the enemies within
Drexler, H. G., Uphoff, C. C., Dirks, W. G., & MacLeod, R. A. F. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00136-9 · Cited by 66
Functional genetics and experimental models of human cancer
Zhao, J. J., Roberts, T. M., & Hahn, W. C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.05.005 · Cited by 71
“1 Masters, J.R. (2000) Human cancer cell lines: fact and fantasy.”
BackgroundVaughan, L., Glänzel, W., Korch, C., & Capes-Davis, A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2258 · Cited by 63
“Cancer cell lines, such as the cervical carcinoma cell line HeLa (1), are used as models by many 64 laboratories to explore cancer biology and test therapeutic agents (2,3).”
BackgroundMethodIncreased resistance of glioma cell lines to extracellular ATP cytotoxicity
Morrone, F. B., Horn, A. P., Stella, J., Spiller, F., Sarkis, J. J. F., Salbego, C. G., Lenz, G., & Battastini, A. M. O. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-1383-1 · Cited by 62
“This similarity makes cancer cell lines a good model for several aspects of cancer biology [33].”
Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities
Yang, Y.-P., Giret, T. M., & Côté, R. J. (2021) · Cancers · doi:10.3390/cancers13112723 · Cited by 63
Three‐dimensional in vitro cell biology models of ovarian and endometrial cancer
Grun, B., Benjamin, E., Sinclair, J., Timms, J. F., Jacobs, I. J., Gayther, S. A., & Dafou, D. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00579.x · Cited by 60
Vécsey-Semjén, B., Becker, K., Sinski, A., Blennow, E., Vietor, I., Zatloukal, K., Beug, H., Wagner, E., & Huber, L. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205577 · Cited by 66
“Ideally, one would like to establish carcinoma cell cultures from each patient in parallel with healthy tissue samples (as reviewed by Masters, 2000).”
BackgroundAtienzar, F. A., Blomme, E. A., Chen, M., Hewitt, P., Kenna, J. G., Labbe, G., Moulin, F., Pognan, F., Roth, A. B., Suter-Dick, L., et al. (2016) · BioMed Research International · doi:10.1155/2016/9737920 · Cited by 59
“Primary cells usually are less abnormal in their overall biology compared to transformed cells lines, which are derived from tumors and continue proliferating even after reaching confluency in monolayers [50].”
BackgroundWANG, H. J., Huang, S., Shou, J., Su, E. W., Onyia, J. E., Liao, B., & Li, S. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-166 · Cited by 58
“Many factors such as cross-contamination can cause cell line misclassification [2].”
BackgroundProteomic approaches to identify biomarkers predictive of radiotherapy outcomes
Lacombe, J., Azria, D., Mangé, A., & Solassol, J. (2013) · Expert Review of Proteomics · doi:10.1586/epr.12.68 · Cited by 57
Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer
Xie, B., & Wu, A. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.191782 · Cited by 54
“Plentiful malignant phenotypes in internal tumors are lost in 2D condition because most cell lines are derived from advanced cancers.[11] Furthermore, monolayer culture cells lack the spatial structure and the interaction between tumor cells and extracellular matrix.”
BackgroundOncogenic transformation and experimental models of human cancer
Anna, C. S. (2007) · Frontiers in bioscience · doi:10.2741/2661 · Cited by 63
“Unlike tumors, cell lines are generally clonal and therefore it is much easier to examine their underlying genetic abnormalities (8).”
BackgroundWitt, B. L., & Tollefsbol, T. O. (2023) · Life · doi:10.3390/life13122311 · Cited by 73
Pal, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805274-7.00004-x · Cited by 53
Emerging Opportunities for Target Discovery in Rare Cancers
Sharifnia, T., Hong, A. L., Painter, C. A., & Boehm, J. S. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.002 · Cited by 51
Mistaken Identity of Widely Used Esophageal Adenocarcinoma Cell Line TE-7
Boonstra, J. J., van der Velden, A. W., Beerens, E. C. W., van Marion, R., Morita-Fujimura, Y., Matsui, Y., Nishihira, T., Tselepis, C., Hainaut, P., Lowe, A. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2064 · Cited by 50
“An important prerequisite of cell line research is the authenticity of the used cell lines because the mistaken identity of a cell line may lead to invalid conclusions (3).”
Algorithms for Drug Sensitivity Prediction
Niz, C. D., Rahman, R., Zhao, X., & Pal, R. (2016) · Algorithms · doi:10.3390/a9040077 · Cited by 59
“Cancer cell lines are expected to reflect the properties (such as genotypic and phenotypic characteristics, mutation status, gene expression and drug sensitivity) of the original cancer type from which they were cultured [2,3].”
BackgroundCariati, M., & Purushotham, A. D. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02895.x · Cited by 67
“Furthermore, large numbers of cells must typically be transplanted to form tumours in xenograft models.(58) There are two possible explanations for these observations.”
BackgroundHo, W. S., Sizdahkhani, S., Hao, S., Song, H., Seldomridge, A. N., Tandle, A. T., Maric, D., Kramp, T. R., Lu, R. O., Heiss, J. D., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.035 · Cited by 54
“While the three cell lines in this study are widely used in meningioma research and well characterized genetically [38, 39], our experimental conclusions are still prone to the usual pitfalls of using human cancer cell lines[40].”
BackgroundHector, A., Koorstra, J.-B. M., Hong, S., Boonstra, J. J., Dinjens, W. N. M., Foratiere, A. A., Wu, T. T., Montgomery, E. A., Eshleman, J. R., & Maitra, A. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.11.6723 · Cited by 47
Walker, C. W., Böttger, S. A., Mulkern, J., Jerszyk, E., Litvaitis, M. K., & Lesser, M. P. (2009) · Biological Bulletin · doi:10.1086/bblv216n1p23 · Cited by 47
Glioblastoma modeling with 3D organoids: progress and challenges
Wang, X., Sun, Y., Zhang, D. Y., Ming, G.-L., & Song, H. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad008 · Cited by 46
“Patient-derived 2D cell lines have been commonly used as convenient and well-established experimental tools [25–27].”
MethodEarly Assessment and Correlations of Nanoclay’s Toxicity to Their Physical and Chemical Properties
Wagner, A., White, A. P., Stueckle, T. A., Banerjee, D. A., Sierros, K. A., Rojanasakul, Y., Agarwal, S., Gupta, R. K., & Dinu, C. Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06657 · Cited by 48
Mouriaux, F., Zaniolo, K., Bergeron, M., Weidmann, C., de la Fouchardière, A., Fournier, F., Droit, A., Morcos, M., Landreville, S., & Guérin, S. L. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19317 · Cited by 61
Multidimensional profiling of drug‐treated cells by Imaging Mass Cytometry
Bouzekri, A., Esch, A. M., & Ornatsky, O. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12692 · Cited by 50
“Discovery of new treatments in oncology research relies extensively on the use of human-derived cell culture models [1].”
BackgroundIL-7–dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL
Barata, J. T., Boussiotis, V. A., Yunes, J. A., Ferrando, A. A., Moreau, L. A., Veiga, J. P., Sallan, S. E., Look, A. T., Nadler, L. M., & Cardoso, A. A. (2003) · Blood · doi:10.1182/blood-2002-12-3861 · Cited by 47
Tesfaye, A. A., Kamgar, M., Azmi, A. S., & Philip, P. A. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1417844 · Cited by 48
Extracellular Matrix-Based Hydrogels to Tailoring Tumor Organoids
Lee, H. J., Mun, S., Pham, D. M., & Kim, P. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01801 · Cited by 47
False cell lines: The problem and a solution
Masters, J. R. (2002) · Cytotechnology · doi:10.1023/a:1022908930937 · Cited by 51
Self-citationElimination of mycoplasma from leukemia–lymphoma cell lines using antibiotics
Uphoff, C., Meyer, C., & Drexler, H. (2002) · Leukemia · doi:10.1038/sj.leu.2402364 · Cited by 40
Geeleher, P., Cox, N. J., & Huang, R. S. (2016) · Genome biology · doi:10.1186/s13059-016-1050-9 · Cited by 47
Disruption of the FA/BRCA pathway in bladder cancer
Neveling, K., Kalb, R., Florl, A. R., Herterich, S., Friedl, R., Hoehn, H., Hader, C., Hartmann, F. H., Nanda, I., Steinlein, C., et al. (2007) · Cytogenetic and Genome Research · doi:10.1159/000108297 · Cited by 44
Kumar, R., Singh, H., Mazumder, A., Salahuddin, Yadav, R. K., Chauhan, B., & Abdulah, M. M. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220810153735 · Cited by 44
Benkendorff, K., McIver, C. M., & Abbott, C. A. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep042 · Cited by 36
“These differences could be due to variability in growth parameters of different cultures of the same cell line [37, 38] or variability in proportion of bioactive compounds present in the extracts from the egg masses.”
Saletta, F., Matullo, G., Manuguerra, M., Arena, S., Bardelli, A., & Vineis, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4420 · Cited by 36
“RT112 is a DNA repair–proficient cell line derived from a human epithelial bladder carcinoma (24) that we found to be chromosomally stable.”
BackgroundTranslating Lung Function Genome-Wide Association Study (GWAS) Findings
Kheirallah, A. K., Miller, S., Hall, I. P., & Sayers, I. (2016) · Advances in genetics · doi:10.1016/bs.adgen.2015.12.002 · Cited by 40
“Different chromosomal re-arrangements, alteration of chromatin, DNA methylation as well as histone methylation patterns may be observed in cell lines (Masters, 2000).”
BackgroundKnowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance
Emad, A., Cairns, J., Kalari, K. R., Wang, L., & Sinha, S. (2017) · Genome biology · doi:10.1186/s13059-017-1282-3 · Cited by 38
“Profiling of cell lines is a promising means to better understand the mechanisms that relate the genomic and transcriptomic features to many different phenotypic outcomes [74].”
Background
Metadata
- Authors
- Masters, J. R. W.
- Affiliations
- University College London (GB)
- Corresponding author
- Masters, John R. W.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2000-12
- Volume
- 1
- Issue
- 3
- Pages
- 233-236
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2075438156
- Cited by
- 352
- References
- 35
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 13 · 2023: 19 · 2022: 18 · 2021: 23 · 2020: 15 · 2019: 15 · 2018: 19 · 2017: 29 · 2016: 23 · 2015: 13 · 2014: 14 · 2013: 14 · 2012: 7
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cancer cell lines, cell line authentication, cell line contamination
- MeSH terms
- Animals, Cells, Cultured, Genotype, Humans, Mycoplasma, Neoplasms, Phenotype, Tumor Cells, Cultured
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.